Live Conference updates

Live Conference news coverage of developments with the latest updates. Stay on top of latest Conference news stories and find out what just happened, what is going on with Conference. The latest real-time news updates and headlines on Conference
Decade Since APS Apology to Aboriginal Peoples
Sober Check to Unveil Impairment Solutions at HASANZ 2026
OrigamiSat-2 Tests Origami Antenna in Space
Class II/III BRAF Alterations in NSCLC: Unique Outcomes
New Immunotherapy Doubles Survival in Advanced NSCLC
Early Brain Radiation Benefits EGFR-mutant NSCLC Patients
IASLC Tumor Budding Grade Flags High-Risk Lung Cancer
Mobile CT Expands Lung Screening for Brazil's Underserved
Meink Unveils Affordable Air, Space Forces Update Plan
CSAF Lauds Airmen Prepared to Fight, Endure, Win
North Shore Urges Minns to Fund Marian St Arts Centre
20-minute STI Testing? Some Relationships Finish Faster
Georgetown Reveals PAPILLON Trial: Long-Term Lung Cancer Survival
MRI Brain Watch Beats Cranial Radiation in Lung Cancer
AUKUS at Five: Progress Measured on Three Metrics
UN Warns Sudan Humanitarian System Near Collapse
Experts Probe Building Resilience Against Climate Strain
Magma Shows Repeated Break-Heal Cycle in Eruptions
IAEA Chief Vows Commitment to Nuclear Safety, Verification
SecAF Unveils New Collaborative Combat Aircraft Names
El Hishri Trial Set to Open May 4, 2027
Nicaragua Inquiry Commission Convenes Initial Meeting
IAEA Hosts 70th General Conference This Week
AI Chatbots Differ from Humans in Kidney Allocation
Central Asia Women Journalists Boost Ties in Tashkent
Finding Future In Pharmacy
Big AI Calls for Research Slowdown: Safety or Strategy?
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
Shadow Minister Forms Advisory Group Post-Funding Plan
Homicide Detectives Renew Appeal in Bowraville Murders
Amivantamab-Chemo Yields Best Survival in EGFR NSCLC
Zidesamtinib Shows 93% Response in ROS1-positive NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
Justin Gooding's Journey From Discovery To Impact
Australia Urged to Double Efforts for Climate Goals
Aussie PM Holds Press Conference at Admiralty House
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Ivonescimab Boosts Survival in PD-L1+ Advanced NSCLC
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
Pumitamig Plus Elfetabart Shows Promise in Lung Cancer
Tarlatamab Dosing Shows Promise in Small Cell Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Phase 1 Backs Phase 3 Dose for Lung Cancer Drug
Atezolizumab Combo Doubles Event-Free Survival in NSCLC